McCormick (MKC) Is Up 9.5% After Margin Gains And Outlook Reaffirmation Has The Bull Case Changed?
McCormick & Company, Incorporated MKC | 0.00 |
- In late June 2026, McCormick & Company reported past second-quarter results showing sales rising to US$1,936.6 million from US$1,659.5 million year on year, while net income eased to US$150.1 million from US$175 million and earnings per share fell to US$0.56 from US$0.65.
- Alongside this earnings beat versus analyst expectations, McCormick reaffirmed its outlook, highlighted margin gains helped by acquisitions such as McCormick de Mexico, and extended its 102-year dividend record with a US$0.48 quarterly payout.
- With that backdrop, we’ll now examine how this margin expansion and guidance reaffirmation affect McCormick’s existing investment narrative.
Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.
McCormick Investment Narrative Recap
To own McCormick, you have to believe in the durability of global demand for flavor and the company’s ability to protect margins while integrating acquisitions and managing costs. The key near term catalyst is progress on margin expansion, supported by cost savings and recent deals like McCormick de Mexico, while the biggest current risk is execution and demand volatility around large customers and regions. The latest results and guidance reaffirmation do not fundamentally change that balance.
The most relevant recent development for this story is McCormick’s reaffirmed fiscal 2026 outlook alongside its Q2 results, despite mixed headline earnings. Management pointed to gross margin gains helped by productivity initiatives and acquisitions, and reiterated expectations for continued net sales growth and margin expansion. That stance matters for investors focused on whether cost savings and portfolio moves can offset input cost pressures and softer consumer volumes in parts of the business.
Yet despite the reassuring margin story, the complexity and leverage tied to the planned Unilever Foods combination is something investors should be aware of...
McCormick's narrative projects $8.7 billion revenue and $720.3 million earnings by 2029. This requires 7.1% yearly revenue growth and a decrease of about $0.9 billion in earnings from $1.6 billion today.
Uncover how McCormick's forecasts yield a $61.23 fair value, a 20% upside to its current price.
Exploring Other Perspectives
Some of the lowest estimate analysts were already cautious, assuming earnings could fall toward about US$842 million by 2029, and this latest quarter may either soften or challenge that more pessimistic view depending on how you judge the quality and sustainability of the reported growth.
Explore 5 other fair value estimates on McCormick - why the stock might be worth over 2x more than the current price!
The Verdict Is Yours
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your McCormick research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
- Our free McCormick research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate McCormick's overall financial health at a glance.
Searching For A Fresh Perspective?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- Uncover the next big thing with 21 elite penny stocks that balance risk and reward.
- AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
